Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 145

1.

Cost-Minimization Analysis of Multidose and Single-Dose Packaging of Contrast Media for Contrast-Enhanced CT: Results From Real-World Data in China.

Wei Y, He Z, Zhang C, Ming J, Fan Z, Ma F, Shi L.

AJR Am J Roentgenol. 2020 Mar 24:1-10. doi: 10.2214/AJR.19.22006. [Epub ahead of print]

PMID:
32208008
2.

Effectiveness of sodium-glucose co-transporter-2 inhibitors on ischemic heart diseases.

Shen Y, Zhou J, Shi L, Nauman E, Katzmarzyk PT, Price-Haywood EG, Horswell R, Chu S, Yang S, Bazzano AN, Nigam S, Hu G.

Diabetes Obes Metab. 2020 Mar 12. doi: 10.1111/dom.14025. [Epub ahead of print]

PMID:
32166884
3.

A Systematic Review of Cost-Effectiveness of Sodium-Glucose Cotransporter Inhibitors for Type 2 Diabetes.

Yoshida Y, Cheng X, Shao H, Fonseca VA, Shi L.

Curr Diab Rep. 2020 Mar 12;20(4):12. doi: 10.1007/s11892-020-1292-5. Review.

PMID:
32166504
4.

EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China.

Zhang Y, Wu J, Chen Y, Shi L.

Diabetes Ther. 2020 Mar 9. doi: 10.1007/s13300-020-00788-z. [Epub ahead of print]

PMID:
32152932
5.

Clinical Effectiveness of Decision Support for Prescribing Opioids for Chronic Noncancer Pain: A Prospective Cohort Study.

Price-Haywood EG, Burton J, Burstain T, Harden-Barrios J, Lefante J, Shi L, Jamison RN, Bazzano A, Bazzano L.

Value Health. 2020 Feb;23(2):157-163. doi: 10.1016/j.jval.2019.09.2748. Epub 2019 Nov 22.

PMID:
32113620
6.

Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study.

Peng XV, Ayyagari R, Lubwama R, Shi L, Price-Haywood EG, Hollander P, Fonseca V.

Diabetes Ther. 2020 Feb 28. doi: 10.1007/s13300-020-00783-4. [Epub ahead of print]

PMID:
32112204
7.

Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experiments.

Sun H, Wang H, Shi L, Wang M, Li J, Shi J, Ni M, Hu X, Chen Y.

BMJ Open. 2020 Feb 12;10(2):e032336. doi: 10.1136/bmjopen-2019-032336.

8.

Association between Hemoglobin A1c and Stroke Risk in Patients with Type 2 Diabetes.

Shen Y, Shi L, Nauman E, Katzmarzyk P, Price-Haywood E, Bazzano A, Nigam S, Hu G.

J Stroke. 2020 Jan;22(1):87-98. doi: 10.5853/jos.2019.01704. Epub 2020 Jan 31.

9.

Does the Encounter Type Matter When Defining Diabetes Complications in Electronic Health Records?

Hong D, Shen Y, Monnette A, Liu S, Shao H, Nauman E, Price-Haywood E, Hu G, Shi L.

Med Care. 2020 Feb 10. doi: 10.1097/MLR.0000000000001297. [Epub ahead of print]

PMID:
32011424
10.
11.

Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider.

Geer EB, Sisco J, Adelman DT, Ludlam WH, Haviv A, Gelbaum D, Liu S, Mathias SD, Shi L.

Pituitary. 2020 Apr;23(2):140-148. doi: 10.1007/s11102-019-01013-2.

12.

Addressing Regional Differences in Diabetes Progression: Global Calibration for Diabetes Simulation Model.

Shao H, Yang S, Stoecker C, Fonseca V, Hong D, Shi L.

Value Health. 2019 Dec;22(12):1402-1409. doi: 10.1016/j.jval.2019.08.007. Epub 2019 Oct 11.

PMID:
31806197
13.

Mapping of Health Technology Assessment in China: Situation Analysis and International Comparison.

Chen Y, Chi X, He Y, Wei Y, Oortwijn W, Shi L.

Int J Technol Assess Health Care. 2019;35(5):401-407. doi: 10.1017/S0266462319000709. Epub 2019 Oct 28.

PMID:
31657287
14.

Association between Body Mass Index and Stroke Risk Among Patients with Type 2 Diabetes.

Shen Y, Shi L, Nauman E, Katzmarzyk PT, Price-Haywood EG, Bazzano AN, Nigam S, Hu G.

J Clin Endocrinol Metab. 2020 Jan 1;105(1). pii: dgz032. doi: 10.1210/clinem/dgz032.

PMID:
31529060
15.

Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review.

Hong D, Si L, Jiang M, Shao H, Ming WK, Zhao Y, Li Y, Shi L.

Pharmacoeconomics. 2019 Dec;37(12):1553. doi: 10.1007/s40273-019-00833-1.

PMID:
31485924
16.

Second-line rituximab-bendamustine versus rituximab-gemcitabine-oxaliplatin in diffuse large B-cell lymphoma in the real world.

Ionescu-Ittu R, Shang A, Velde NV, Guerin A, Lin Y, Shi L, Shi S, Qayum N.

J Comp Eff Res. 2019 Oct;8(13):1067-1075. doi: 10.2217/cer-2019-0062. Epub 2019 Aug 27.

17.

Serum uric acid as a risk factor of all-cause mortality and cardiovascular events among type 2 diabetes population: Meta-analysis of correlational evidence.

Shao Y, Shao H, Sawhney MS, Shi L.

J Diabetes Complications. 2019 Oct;33(10):107409. doi: 10.1016/j.jdiacomp.2019.07.006. Epub 2019 Jul 25. Review.

PMID:
31439471
18.

Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus.

Shi Q, Liu S, Fonseca VA, Thethi TK, Shi L.

BMJ Open. 2019 Jul 30;9(7):e024954. doi: 10.1136/bmjopen-2018-024954.

19.

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.

Kent S, Becker F, Feenstra T, Tran-Duy A, Schlackow I, Tew M, Zhang P, Ye W, Lizheng S, Herman W, McEwan P, Schramm W, Gray A, Leal J, Lamotte M, Willis M, Palmer AJ, Clarke P.

Pharmacoeconomics. 2019 Nov;37(11):1305-1312. doi: 10.1007/s40273-019-00825-1.

20.

Cervical Cancer Mortality in Younger Women.

Zhou P, Chen D, Shi L.

J Gen Intern Med. 2020 Feb;35(2):592. doi: 10.1007/s11606-019-05183-4. No abstract available.

PMID:
31346905

Supplemental Content

Loading ...
Support Center